Trials / Unknown
UnknownNCT03404414
Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT
Detection of Functioning Pituitary Microadenoma With Inconclusive MRI Findings: PET/MRI Versus PET/CT
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective case-control study to compare the usefulness of 18F-FDG PET/MRI with that of 18F-FDG PET/CT in detection of functioning pituitary microadenomas.A single dose of 370 Mega-Becquerel (MBq) 18F-FDG will be injected intravenously.Visual and semiquantitative method will be used to assess the PET/MRI and PET/CT images.
Detailed description
Magnetic resonance imaging (MRI) may be insufficient to locate functioning pituitary microadenoma.This study compared the usefulness of 18F-FDG PET/MRI with that of 18F-FDG PET/CT in detection of functioning pituitary microadenomas in patients with inconclusive conventional MRI findings. Trans-sphenoidal adenomectomy was performed within 2 weeks of imaging.The PET/CT and PET/MRI findings and tracer uptake levels were correlated with the surgical findings and pathological results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 18F-FDG | Single-dose 18F-FDG were injected into the patients before the PET/MR or PET/CT scans. patients before the PET/CT scans |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2018-11-01
- Completion
- 2018-11-01
- First posted
- 2018-01-19
- Last updated
- 2018-01-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03404414. Inclusion in this directory is not an endorsement.